nodes	percent_of_prediction	percent_of_DWPC	metapath
Proflavine—F2—malignant glioma	0.899	1	CbGaD
Proflavine—F2—vertebral column—malignant glioma	0.0173	0.455	CbGeAlD
Proflavine—F2—endothelium—malignant glioma	0.0077	0.202	CbGeAlD
Proflavine—F2—blood vessel—malignant glioma	0.0071	0.187	CbGeAlD
Proflavine—F2—Syndecan-4-mediated signaling events—MDK—malignant glioma	0.00302	0.0481	CbGpPWpGaD
Proflavine—F2—spinal cord—malignant glioma	0.00241	0.0635	CbGeAlD
Proflavine—F2—central nervous system—malignant glioma	0.00196	0.0515	CbGeAlD
Proflavine—F2—Intrinsic Pathway—KNG1—malignant glioma	0.00175	0.0278	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—TNC—malignant glioma	0.00172	0.0273	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—malignant glioma	0.00165	0.0262	CbGpPWpGaD
Proflavine—F2—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.00162	0.0258	CbGpPWpGaD
Proflavine—F2—brain—malignant glioma	0.00155	0.0409	CbGeAlD
Proflavine—F2—Complement and Coagulation Cascades—CFH—malignant glioma	0.00155	0.0247	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—ATP1B2—malignant glioma	0.00129	0.0206	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—CSF1—malignant glioma	0.00124	0.0197	CbGpPWpGaD
Proflavine—F2—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.00123	0.0196	CbGpPWpGaD
Proflavine—F2—Formation of Fibrin Clot (Clotting Cascade)—KNG1—malignant glioma	0.00118	0.0188	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—PTK2—malignant glioma	0.00111	0.0176	CbGpPWpGaD
Proflavine—F2—Regulation of IGF Activity by IGFBP—MMP2—malignant glioma	0.000995	0.0158	CbGpPWpGaD
Proflavine—F2—Platelet Aggregation (Plug Formation)—PTK2—malignant glioma	0.000984	0.0157	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—ANGPT2—malignant glioma	0.000953	0.0152	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—FGFR1—malignant glioma	0.000924	0.0147	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—FN1—malignant glioma	0.000838	0.0133	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—SOD1—malignant glioma	0.000829	0.0132	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—IFNG—malignant glioma	0.000799	0.0127	CbGpPWpGaD
Proflavine—F2—Complement and Coagulation Cascades—KNG1—malignant glioma	0.000795	0.0126	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—MYLK—malignant glioma	0.000792	0.0126	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—PTK2—malignant glioma	0.000774	0.0123	CbGpPWpGaD
Proflavine—F2—Platelet Aggregation (Plug Formation)—FN1—malignant glioma	0.000746	0.0119	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—IL1B—malignant glioma	0.000713	0.0113	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000707	0.0113	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—FGF2—malignant glioma	0.000675	0.0107	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—SOD1—malignant glioma	0.000675	0.0107	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—MMP9—malignant glioma	0.000672	0.0107	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—CAT—malignant glioma	0.000641	0.0102	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—FN1—malignant glioma	0.000586	0.00933	CbGpPWpGaD
Proflavine—F2—Hemostasis—DOCK6—malignant glioma	0.000578	0.0092	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—PTPN11—malignant glioma	0.000551	0.00877	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000536	0.00853	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—MMP9—malignant glioma	0.000534	0.0085	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—CAT—malignant glioma	0.000509	0.0081	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCR4—malignant glioma	0.000504	0.00802	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—malignant glioma	0.000497	0.00791	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—FGF2—malignant glioma	0.000472	0.00751	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—PIK3CA—malignant glioma	0.000471	0.0075	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IFNG—malignant glioma	0.000437	0.00696	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—BDKRB2—malignant glioma	0.000416	0.00662	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IL1B—malignant glioma	0.00039	0.00621	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.000375	0.00596	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—CAV1—malignant glioma	0.000357	0.00567	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IFNG—malignant glioma	0.000356	0.00566	CbGpPWpGaD
Proflavine—F2—Hemostasis—ATP1B2—malignant glioma	0.00035	0.00558	CbGpPWpGaD
Proflavine—F2—G alpha (q) signalling events—BDKRB2—malignant glioma	0.000347	0.00552	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.000343	0.00545	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—FN1—malignant glioma	0.000339	0.0054	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.000338	0.00538	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PTK2—malignant glioma	0.000323	0.00514	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—PTPN11—malignant glioma	0.000319	0.00508	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL1B—malignant glioma	0.000317	0.00505	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL2—malignant glioma	0.000316	0.00503	CbGpPWpGaD
Proflavine—F2—G alpha (q) signalling events—KNG1—malignant glioma	0.000316	0.00502	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—KNG1—malignant glioma	0.000312	0.00496	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00031	0.00494	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PDGFRA—malignant glioma	0.000302	0.00481	CbGpPWpGaD
Proflavine—F2—PAR1-mediated thrombin signaling events—PIK3CA—malignant glioma	0.000296	0.0047	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—malignant glioma	0.000288	0.00458	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—TNF—malignant glioma	0.000283	0.0045	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IFNG—malignant glioma	0.000283	0.0045	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.000282	0.00449	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000276	0.0044	CbGpPWpGaD
Proflavine—F2—Platelet Aggregation (Plug Formation)—AKT1—malignant glioma	0.000272	0.00433	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PDGFB—malignant glioma	0.000271	0.00432	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000271	0.00431	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—FGFR1—malignant glioma	0.00027	0.00429	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—malignant glioma	0.000262	0.00417	CbGpPWpGaD
Proflavine—F2—Hemostasis—ANGPT2—malignant glioma	0.000258	0.00411	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCR4—malignant glioma	0.000257	0.0041	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000257	0.00408	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IL1B—malignant glioma	0.000252	0.00401	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.000251	0.004	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00025	0.00398	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—XBP1—malignant glioma	0.000249	0.00397	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—PIK3CB—malignant glioma	0.000249	0.00396	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—FN1—malignant glioma	0.000245	0.00389	CbGpPWpGaD
Proflavine—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000237	0.00377	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000236	0.00375	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—APC—malignant glioma	0.000234	0.00373	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PIK3CG—malignant glioma	0.000234	0.00373	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—EGF—malignant glioma	0.000232	0.00368	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—TNF—malignant glioma	0.00023	0.00366	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00023	0.00366	CbGpPWpGaD
Proflavine—F2—Hemostasis—HIST1H3B—malignant glioma	0.000224	0.00356	CbGpPWpGaD
Proflavine—F2—Hemostasis—MYB—malignant glioma	0.000222	0.00353	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—BRAF—malignant glioma	0.00022	0.0035	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—LATS2—malignant glioma	0.00022	0.0035	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.000214	0.00341	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000209	0.00333	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	0.000206	0.00328	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—TP53—malignant glioma	0.000203	0.00323	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000198	0.00315	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	0.000197	0.00314	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCR3—malignant glioma	0.000191	0.00304	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—SPHK1—malignant glioma	0.000185	0.00294	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	0.000184	0.00292	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—TNF—malignant glioma	0.000183	0.00291	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	0.000179	0.00286	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000179	0.00284	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—BDKRB2—malignant glioma	0.000175	0.00278	CbGpPWpGaD
Proflavine—F2—Hemostasis—H3F3A—malignant glioma	0.000173	0.00275	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000172	0.00273	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000171	0.00272	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000169	0.00269	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—LATS1—malignant glioma	0.000167	0.00265	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—KRAS—malignant glioma	0.000165	0.00263	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—KNG1—malignant glioma	0.000159	0.00253	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000156	0.00249	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—PIK3CA—malignant glioma	0.000152	0.00241	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.00015	0.00239	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCR4—malignant glioma	0.000146	0.00232	CbGpPWpGaD
Proflavine—F2—Hemostasis—KNG1—malignant glioma	0.000142	0.00227	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.000142	0.00226	CbGpPWpGaD
Proflavine—F2—Hemostasis—IFNA2—malignant glioma	0.000139	0.00222	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000137	0.00218	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000134	0.00213	CbGpPWpGaD
Proflavine—F2—Hemostasis—SOD1—malignant glioma	0.000132	0.0021	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCR4—malignant glioma	0.000132	0.0021	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000131	0.00208	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—BCHE—malignant glioma	0.000128	0.00203	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	0.000126	0.00201	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—FBXW7—malignant glioma	0.000126	0.002	CbGpPWpGaD
Proflavine—F2—Hemostasis—PTK2—malignant glioma	0.000121	0.00193	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.00012	0.00191	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	0.000119	0.00189	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MDK—malignant glioma	0.000113	0.00179	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	0.000109	0.00174	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCR3—malignant glioma	0.000108	0.00172	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—DTX1—malignant glioma	0.000107	0.00171	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000102	0.00163	CbGpPWpGaD
Proflavine—F2—Hemostasis—PDGFB—malignant glioma	0.000102	0.00162	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—BDKRB2—malignant glioma	9.89e-05	0.00157	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCR3—malignant glioma	9.82e-05	0.00156	CbGpPWpGaD
Proflavine—F2—Hemostasis—CAV1—malignant glioma	9.67e-05	0.00154	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	9.52e-05	0.00152	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	9.4e-05	0.0015	CbGpPWpGaD
Proflavine—F2—Hemostasis—FN1—malignant glioma	9.2e-05	0.00146	CbGpPWpGaD
Proflavine—F2—G alpha (q) signalling events—PIK3CA—malignant glioma	9.12e-05	0.00145	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—KNG1—malignant glioma	9e-05	0.00143	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—BDKRB2—malignant glioma	8.98e-05	0.00143	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	8.88e-05	0.00141	CbGpPWpGaD
Proflavine—F2—Hemostasis—PIK3CG—malignant glioma	8.81e-05	0.0014	CbGpPWpGaD
Proflavine—F2—Hemostasis—EGF—malignant glioma	8.71e-05	0.00139	CbGpPWpGaD
Proflavine—F2—Hemostasis—PTPN11—malignant glioma	8.65e-05	0.00138	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—SUFU—malignant glioma	8.53e-05	0.00136	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—HEY2—malignant glioma	8.43e-05	0.00134	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—GFAP—malignant glioma	8.23e-05	0.00131	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—KNG1—malignant glioma	8.17e-05	0.0013	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	8.16e-05	0.0013	CbGpPWpGaD
Proflavine—F2—Hemostasis—AKT2—malignant glioma	8.06e-05	0.00128	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	7.98e-05	0.00127	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—SPHK1—malignant glioma	7.97e-05	0.00127	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—HEY1—malignant glioma	7.81e-05	0.00124	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCR4—malignant glioma	7.81e-05	0.00124	CbGpPWpGaD
Proflavine—F2—Hemostasis—PIK3CD—malignant glioma	7.74e-05	0.00123	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—HIST1H3B—malignant glioma	7.58e-05	0.00121	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCL8—malignant glioma	7.25e-05	0.00115	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—MMP3—malignant glioma	7.24e-05	0.00115	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—JAG2—malignant glioma	6.92e-05	0.0011	CbGpPWpGaD
Proflavine—F2—Hemostasis—RAF1—malignant glioma	6.91e-05	0.0011	CbGpPWpGaD
Proflavine—F2—Hemostasis—PIK3CB—malignant glioma	6.75e-05	0.00107	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—AKT1—malignant glioma	6.52e-05	0.00104	CbGpPWpGaD
Proflavine—F2—Hemostasis—IL2—malignant glioma	6.2e-05	0.000986	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—MMP2—malignant glioma	6.14e-05	0.000977	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—H3F3A—malignant glioma	5.86e-05	0.000932	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCR3—malignant glioma	5.8e-05	0.000923	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NTRK2—malignant glioma	5.64e-05	0.000898	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—YWHAE—malignant glioma	5.64e-05	0.000898	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—FLT1—malignant glioma	5.62e-05	0.000894	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—DUSP6—malignant glioma	5.59e-05	0.00089	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—PIK3CG—malignant glioma	5.57e-05	0.000886	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—JAG1—malignant glioma	5.52e-05	0.000879	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NOTCH3—malignant glioma	5.5e-05	0.000875	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—FBXW7—malignant glioma	5.41e-05	0.000861	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—BDKRB2—malignant glioma	5.31e-05	0.000844	CbGpPWpGaD
Proflavine—F2—Hemostasis—VEGFA—malignant glioma	5.27e-05	0.000838	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—CXCL8—malignant glioma	5.1e-05	0.000812	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—AKT2—malignant glioma	5.09e-05	0.00081	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—PIK3CG—malignant glioma	5.05e-05	0.000804	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—PTPN11—malignant glioma	4.97e-05	0.00079	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NOTCH2—malignant glioma	4.93e-05	0.000785	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—PIK3CD—malignant glioma	4.89e-05	0.000779	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—KNG1—malignant glioma	4.83e-05	0.000768	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—AKT2—malignant glioma	4.62e-05	0.000736	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NTRK1—malignant glioma	4.6e-05	0.000732	CbGpPWpGaD
Proflavine—F2—Hemostasis—KRAS—malignant glioma	4.48e-05	0.000712	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—PIK3CD—malignant glioma	4.44e-05	0.000707	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MMP3—malignant glioma	4.28e-05	0.00068	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—PIK3CB—malignant glioma	4.26e-05	0.000679	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CDKN2B—malignant glioma	4.24e-05	0.000675	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PTK2—malignant glioma	4.12e-05	0.000655	CbGpPWpGaD
Proflavine—F2—Hemostasis—PIK3CA—malignant glioma	4.11e-05	0.000655	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCL8—malignant glioma	4.1e-05	0.000652	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—HES1—malignant glioma	4.04e-05	0.000643	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NCOR1—malignant glioma	4.02e-05	0.00064	CbGpPWpGaD
Proflavine—F2—Hemostasis—TP53—malignant glioma	3.98e-05	0.000633	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—RAF1—malignant glioma	3.97e-05	0.000631	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—IL2—malignant glioma	3.92e-05	0.000623	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—PIK3CB—malignant glioma	3.87e-05	0.000616	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PDGFRA—malignant glioma	3.85e-05	0.000613	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—SPP1—malignant glioma	3.74e-05	0.000595	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCL8—malignant glioma	3.72e-05	0.000592	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL2—malignant glioma	3.56e-05	0.000566	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TERT—malignant glioma	3.54e-05	0.000564	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PDGFB—malignant glioma	3.46e-05	0.00055	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—FGFR1—malignant glioma	3.44e-05	0.000548	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—HIF1A—malignant glioma	3.39e-05	0.000539	CbGpPWpGaD
Proflavine—F2—Hemostasis—AKT1—malignant glioma	3.36e-05	0.000535	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CAV1—malignant glioma	3.28e-05	0.000522	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—KDR—malignant glioma	3.24e-05	0.000516	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—FN1—malignant glioma	3.12e-05	0.000496	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—BAD—malignant glioma	3.08e-05	0.000491	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NOTCH1—malignant glioma	3.05e-05	0.000486	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CD80—malignant glioma	2.99e-05	0.000476	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PIK3CG—malignant glioma	2.99e-05	0.000475	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—APC—malignant glioma	2.99e-05	0.000475	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—EGF—malignant glioma	2.95e-05	0.00047	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PTPN11—malignant glioma	2.93e-05	0.000467	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—BRAF—malignant glioma	2.81e-05	0.000447	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—AKT2—malignant glioma	2.73e-05	0.000435	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—EGFR—malignant glioma	2.72e-05	0.000433	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PIK3CD—malignant glioma	2.62e-05	0.000418	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—PIK3CA—malignant glioma	2.6e-05	0.000414	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—KRAS—malignant glioma	2.57e-05	0.000409	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—FGF2—malignant glioma	2.51e-05	0.0004	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—PIK3CA—malignant glioma	2.36e-05	0.000376	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MDM2—malignant glioma	2.35e-05	0.000374	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—RAF1—malignant glioma	2.34e-05	0.000373	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—ERBB2—malignant glioma	2.32e-05	0.000369	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PIK3CB—malignant glioma	2.29e-05	0.000364	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCL8—malignant glioma	2.2e-05	0.00035	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—AKT1—malignant glioma	2.12e-05	0.000338	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CASP3—malignant glioma	2.1e-05	0.000335	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL2—malignant glioma	2.1e-05	0.000334	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MMP9—malignant glioma	1.99e-05	0.000316	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PTEN—malignant glioma	1.98e-05	0.000315	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—AKT1—malignant glioma	1.93e-05	0.000307	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—VEGFA—malignant glioma	1.79e-05	0.000284	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—STAT3—malignant glioma	1.77e-05	0.000281	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MYC—malignant glioma	1.64e-05	0.000261	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—EGFR—malignant glioma	1.61e-05	0.000256	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—KRAS—malignant glioma	1.52e-05	0.000242	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PIK3CA—malignant glioma	1.39e-05	0.000222	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TP53—malignant glioma	1.35e-05	0.000215	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—AKT1—malignant glioma	1.14e-05	0.000181	CbGpPWpGaD
